Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jai Ha Lee
Introduction
Jai Ha Lee is a prominent inventor based in Daejeon, South Korea. He has made significant strides in the field of cancer treatment through his innovative research and development of novel antibodies. His work focuses on addressing critical challenges in oncology, particularly in the inhibition of cancer cell proliferation.
Latest Patents
One of Jai Ha Lee's notable patents is the "Anti-TM4SF4 antibody and uses thereof." This invention relates to novel antibodies or antigen-binding fragments that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies exhibit proliferation inhibitory activity against cancer cells, effectively preventing or treating cancer. Additionally, they reduce the self-renewal ability of cancer stem cells, making them useful in treating cancers with poor prognoses in conventional anticancer treatments.
Career Highlights
Jai Ha Lee is affiliated with the Korea Atomic Energy Research Institute, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies, showcasing his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include In Gyu Kim and Rae Kwon Kim, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Jai Ha Lee's innovative work in developing antibodies for cancer treatment highlights his significant contributions to medical research. His dedication to improving cancer therapies is evident through his patented inventions and collaborative efforts.